COMMUNIQUÉS West-GlobeNewswire

Philips completes acquisition of Carestream Health’s Healthcare Information Systems business in majority of relevant countries
01/08/2019
August 1, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has completed the previously announced acquisition of Carestream Health Inc [...]
The Alliance for Regenerative Medicine Releases Q2 2019 Global Sector Report, Highlighting Industry Trends and Metrics
01/08/2019
WASHINGTON, D.C., Aug. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly global sector report, offering an in-depth look at cell [...]
Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 7, 2019
01/08/2019
Gaithersburg, Md., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will report [...]
Generex Biotechnology Welcomes MediSource Partners to the NuGenerex Family of Companies
01/08/2019
MediSource Partners Fresh Approach to Healthcare Network of healthcare providers, facilities, suppliers, and distributors Value Analysis Consulting Group Purchasing Distributorship (GPD) https://medisourcepartners.com [...]
INmune Bio Co-Founder and CEO RJ Tesi Presents at Cambridge Healthcare Institute’s 7th Annual Immuno-Oncology Summit
01/08/2019
LA JOLLA, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today [...]
Seelos Therapeutics Reports Q2 2019 Pipeline Update
01/08/2019
NEW YORK, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, today released its second quarter pipeline update. “We have made tremendous progress on [...]
B. Braun Interventional Systems Receives Breakthrough Device Designation Status from the FDA for SeQuent Please ReX Drug Coated PTCA Balloon Catheter
01/08/2019
BETHLEHEM, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- B. Braun Interventional Systems Inc. (BIS) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the SeQuent [...]
UPDATE: CeCors Inc. Amends Articles of Corporation to Prepare for Future Mergers and Acquisitions
01/08/2019
LAS VEGAS, NV, Aug. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CeCors, Inc. (OTC:CEOS) ; a Company focused on the Health & Technology Sector as well as other Emerging Technologies, is pleased to update its [...]
Shineco, Inc. Announces Entry into Strategic Cooperation Agreement for Acquisition of a Leading Chinese Agriculture Technology Company of Industrial Hemp
01/08/2019
BEIJING, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and [...]
Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants
01/08/2019
SAN DIEGO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, [...]
BioSig Allowed Additional Foundational US Patent for its PURE EP(tm) System
01/08/2019
Westport, CT, Aug. 01, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
MediPharm Labs Sets Date to Announce Second Quarter 2019 Financial Results
01/08/2019
TORONTO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation [...]
Statement re Cancellation
01/08/2019
EASTPHARMA LTD (“the Company ” or “ Eastpharma ”) EASTPHARMA’S DELISTING OF ITS GDRS Further to the Company's announcement of 2 May 2019, Eastpharma announces that the cancellation of the the standard listing of its [...]
AZTherapies Completes Enrollment in COGNITE Pivotal Phase 3 Trial of ALZT-OP1 for the Treatment of Early Alzheimer’s Disease
01/08/2019
First-in-class candidate targets microglia to slow or halt neuroinflammation and disease progression ALZT-OP1 trial being conducted under an SPA with expected completion in late 2020 BOSTON, Aug. 01, 2019 (GLOBE [...]
Caladrius Biosciences to Host 2019 Second Quarter Financial Results Conference Call on Thursday, August 8, 2019 at 4:30 p.m. Eastern Time
01/08/2019
BASKING RIDGE, N.J., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company pioneering advancements [...]
Albireo to Report Second Quarter 2019 Financial Results and Host Conference Call and Webcast
01/08/2019
BOSTON, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that management will host a [...]
Acer Therapeutics to Present at the 2019 Webush PacGrow Healthcare Conference
01/08/2019
NEWTON, Mass., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life- [...]
ChemoCentryx to Present at the Canaccord Genuity 39th Annual Growth Conference
01/08/2019
MOUNTAIN VIEW, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the Canaccord Genuity [...]
Nemaura Medical Inc. Announces $8 million Senior Debt Facility Provided by Existing Investors
01/08/2019
Loughborough, England, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive, affordable and flexible [...]

Pages